Our group has received unrestricted educational grants for the development of the guideline and educational materials. The grantors had no authorship or editorial control over the content of our meetings, any subsequent publications or educational materials developed by us.

• CSL Behring GmbH, Octapharma AG and LFB Biomédicaments jointly supported the development of the clinical practice guideline “The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition”
• CSL Behring GmbH supported the development and production of the app and this website